Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
ETON3 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in ETON PHARMACEUTICALS INC
No. Balyasny Asset Management exited its ETON (Eton Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 50,205 shares worth $651,661. Balyasny Asset Management first reported ETON in Q4 2024 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$157,842
Total Shares Change
-11,850
Quarter-by-Quarter History
Other major holders of ETON: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC